title: Differential metal content and gene expression in rat left ventricular hypertrophy due to hypertension and hyperactivity.
abstract: The spontaneously hypertensive rat (SHR) has been studied extensively as a model of left ventricular hypertrophy (LVH) and associated cardiac dysfunction due to hypertension (HT). The SHR also possesses a hyperactive trait (HA). Crossbreeding SHR with Wistar-Kyoto (WKY) control rats, which are nonHT and nonHA, followed by selected inbreeding produced two additional homozygous strains: WKHT and WKHA, in which the traits of HT and HA, respectively, are expressed separately. WKHT, WKHA and SHR all display LVH, but only the SHR exhibits cardiac dysfunction. We hypothesized that cardiac dysfunction in the SHR is uniquely characterized by calcium overload. We measured total cardiac Ca, Cu, Fe, K, Mg and Zn in the four strains. We found elevated Ca and depressed Cu, Mg and Zn with HT, but not unique to SHR. We surmise that HT promotes aberrant regulation of cardiac Ca(2+), Cu(2+), Mg(2+) and Zn(2+), which does not necessarily result in cardiac dysfunction. Interestingly, Cu was elevated in HA strains compared to nonHA counterparts. We then analyzed gene expression as mRNA of Cu-containing proteins, most notably mitochondrial-Cox, Dbh, Lox, Loxl1, Loxl2, Sod1 and Tyr. The gene expression profiles of Lox, Loxl1, Loxl2 and Sod1 were found especially high in the WKHA, which if reflective of protein content could account for the high Cu content in the WKHA. The mRNA of other genes, notably Mb, Fxyd1, Maoa and Maob were also examined. We found that Maoa gene expression and monoamine oxidase-A (MAO-A) protein content were low in the SHR compared to the other strains. The finding that MAO-A protein is low in the SHR and normal in the WKHT and WKHA strains is most consistent with the idea that MAO-A protects against the development of cardiac dysfunction in LVH but not against LVH in these rats.
authors.affiliation: Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405, United States.
authors.forename: Meenakumari
authors.initials: M
authors.lastname: Subramanian
authors.affiliation: Department of Chemistry, University of Vermont, Burlington, VT 05405, United States.
authors.forename: Adam L
authors.initials: AL
authors.lastname: Hunt
authors.affiliation: Department of Chemistry, University of Vermont, Burlington, VT 05405, United States.
authors.forename: Giuseppe A
authors.initials: GA
authors.lastname: Petrucci
authors.affiliation: Department of Medicine, University of Vermont, Burlington, VT 05405, United States.
authors.forename: Zengyi
authors.initials: Z
authors.lastname: Chen
authors.affiliation: Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405, United States.
authors.forename: Edith D
authors.initials: ED
authors.lastname: Hendley
authors.affiliation: Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405, United States. Electronic address: bmpalmer@uvm.edu.
authors.forename: Bradley M
authors.initials: BM
authors.lastname: Palmer
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D003300:Copper / Q000378:metabolism; D006973:Hypertension / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology*; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015032:Zinc / Q000378:metabolism
chemical_list: D003300:Copper; D008995:Monoamine Oxidase; D015032:Zinc; D002118:Calcium
keywords: Calcium; Cardiac hypertrophy; Copper; Monoamine oxidase; Zinc